Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High‐Risk MDS Treated With Nucleoside AnalogsErwann Collomb, Geoffroy Venton, Laurent Bourguignon et al.|Hematological Oncology|2025Cited by 0
Author response for "Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High‐Risk MDS Treated With Nucleoside Analogs"Erwann Collomb, Geoffroy Venton, Guillaume Berton et al.|Unknown|2025Cited by 0